A detailed history of Israel Englander (Millennium Management LLC) transactions in Allakos Inc. stock. As of the latest transaction made, Millennium Management LLC holds 16,800 shares of ALLK stock, worth $23,688. This represents 0.0% of its overall portfolio holdings.

Number of Shares
16,800
Previous 55,400 69.68%
Holding current value
$23,688
Previous $69,000 76.81%
% of portfolio
0.0%
Previous 0.0%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$1.0 - $1.45 $169,675 - $246,028
169,675 Added 5.22%
3,423,095 $3.42 Million
Q1 2024

May 15, 2024

BUY
$1.02 - $3.23 $2.34 Million - $7.4 Million
2,291,706 Added 238.29%
3,253,420 $4.1 Million
Q4 2023

Feb 14, 2024

SELL
$1.72 - $3.18 $476,421 - $880,825
-276,989 Reduced 22.36%
961,714 $2.63 Million
Q2 2023

Aug 14, 2023

BUY
$3.6 - $5.25 $1.24 Million - $1.8 Million
343,338 Added 38.35%
1,238,703 $5.4 Million
Q1 2023

May 15, 2023

BUY
$4.3 - $8.27 $261,246 - $502,443
60,755 Added 7.28%
895,365 $3.98 Million
Q4 2022

Feb 14, 2023

SELL
$5.66 - $8.42 $3.8 Million - $5.66 Million
-672,177 Reduced 44.61%
834,610 $7.03 Million
Q3 2022

Nov 14, 2022

SELL
$3.02 - $6.12 $1.16 Million - $2.34 Million
-382,496 Reduced 20.25%
1,506,787 $9.22 Million
Q2 2022

Aug 15, 2022

SELL
$2.6 - $6.14 $825,988 - $1.95 Million
-317,688 Reduced 14.39%
1,889,283 $5.91 Million
Q1 2022

May 16, 2022

BUY
$5.08 - $9.81 $1.55 Million - $2.98 Million
304,186 Added 15.99%
2,206,971 $12.6 Million
Q4 2021

Feb 14, 2022

BUY
$8.55 - $111.89 $16.2 Million - $213 Million
1,899,899 Added 65831.57%
1,902,785 $18.6 Million
Q3 2021

Nov 15, 2021

SELL
$76.53 - $110.43 $5.34 Million - $7.7 Million
-69,760 Reduced 96.03%
2,886 $306,000
Q2 2021

Aug 16, 2021

BUY
$85.37 - $114.1 $4.41 Million - $5.9 Million
51,668 Added 246.3%
72,646 $6.2 Million
Q1 2021

May 17, 2021

BUY
$109.73 - $153.66 $2.3 Million - $3.22 Million
20,978 New
20,978 $2.41 Million
Q2 2020

Aug 14, 2020

SELL
$44.04 - $80.69 $1.83 Million - $3.35 Million
-41,555 Closed
0 $0
Q1 2020

May 14, 2020

SELL
$44.49 - $93.39 $153,712 - $322,662
-3,455 Reduced 7.68%
41,555 $1.85 Million
Q4 2019

Feb 14, 2020

SELL
$66.49 - $137.73 $1.14 Million - $2.35 Million
-17,094 Reduced 27.52%
45,010 $4.29 Million
Q3 2019

Nov 14, 2019

BUY
$31.0 - $89.73 $1.62 Million - $4.68 Million
52,128 Added 522.53%
62,104 $4.88 Million
Q2 2019

Aug 15, 2019

BUY
$36.0 - $44.73 $359,136 - $446,226
9,976 New
9,976 $432,000
Q1 2019

May 14, 2019

SELL
$33.79 - $51.99 $261,804 - $402,818
-7,748 Closed
0 $0
Q4 2018

Feb 14, 2019

SELL
$31.59 - $62.65 $53,102 - $105,314
-1,681 Reduced 17.83%
7,748 $405,000
Q3 2018

Nov 14, 2018

BUY
$31.25 - $47.64 $294,656 - $449,197
9,429 New
9,429 $424,000

Others Institutions Holding ALLK

About Allakos Inc.


  • Ticker ALLK
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 84,726,096
  • Market Cap $119M
  • Description
  • Allakos Inc., a clinical stage biopharmaceutical company, develops therapeutics that target immunomodulatory receptors present on immune effector cells in allergy, inflammatory, and proliferative diseases. The company's lead monoclonal antibody is lirentelimab (AK002), which is in a Phase III study for the treatment of eosinophilic gastritis and...
More about ALLK
Track Israel Englander's Portfolio

Track Israel Englander Portfolio

Follow Israel Englander (Millennium Management LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.